Back to search

Infex Therapeutics Limited

09990238

active
Private Limited Company
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

MERESIDE, MACCLESFIELD, SK10 4TG
Incorporated 05/02/2016

Compliance

Last accounts

31/07/2025

small

Next accounts due

30/04/2027

On track

Confirmation statement

Last: 30/01/2026

Due 13/02/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Peter Jackson

director · Since 05/02/2016

DIRECTOR

BRITISH · UNITED KINGDOM · Age 63

Also on 7 other boards

Mr Christopher Doherty

director · Since 06/09/2016

DIRECTOR

BRITISH · ENGLAND · Age 65

Also on 1 other board

Mr Jonathan Paul Moulton

director · Since 06/09/2016

DIRECTOR

BRITISH · GUERNSEY · Age 75

Also on 3 other boards

Professor Colm Leonard

director · Since 01/02/2023

PROFESSOR

IRISH · ENGLAND · Age 58

Also on 1 other board

Persons with Significant Control

Infex Therapeutics Holdings Plc

75–100% shares
75–100% votes
Appoint directors

Shoosmiths Llp, 100 Avebury Boulevard, Milton Keynes, MK9 1FH

Reg: 13917179 · The Registrar Of Companies At Companies House · Company Limited By Shares

Notified 06/04/2022

Former PSCs

Moulton Goodies Limited

Ceased 19/07/2017

Catapult Life Sciences Gp Llp

Ceased 06/04/2022

Bruntwood Science Limited

Ceased 21/03/2019

Charges0 outstanding

Charge
satisfied

MOULTON GOODIES LIMITED (AS SECURITY AGENT)

Created 18/10/2023Registered 27/10/2023Satisfied 05/12/2024
Charge
satisfied

MOULTON GOODIES LIMITED

Created 06/04/2022Registered 19/04/2022Satisfied 05/12/2024

CompanyRankvs 999+ SIC 72110 peers
62

Financial strength78th percentile among SIC peers · 20/25
Employees97th percentile among SIC peers · 15/15
LiquidityCurrent ratio 0.29× · 2/20
Longevity10 years trading (max 15) · 10/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength20/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees15/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity10/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/07/2025

Net Worth

£92k

Balance sheet strength

Cash

£97k

Cash in the bank

Net Current Assets

-£1.8M

Working capital

Current Assets

£767k

Current Liabilities

£2.6M

Fixed Assets

£4k

Debtors

£670k

Profit After Tax

£8.2M

24avg. employees+2

Balance Sheet

Assets less current liabilities-£1.8M
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.29+£10.1M
20240.09-£3.9M
20230.83-£3.0M
20220.51-£3.5M
20211.75+£45k
20203.83+£191k
20197.28

Derived from filed accounts. Not audited figures.